Nongenomic actions of estrogens: Exciting opportunities for pharmacology

Maturitas

Volumn 54, Issue 4, 2006, Pages 321-326

  Wehling, Martin ^a   Schultz, Armin ^a   Lösel, Ralf ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Estrogen; Nongenomic actions; Rapid responses; Steroid

Indexed keywords

ACOLBIFENE; ANTIESTROGEN; DAIDZEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; ETHINYLESTRADIOL; FULVESTRANT; GENISTEIN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ARTICLE; AUTOCRINE EFFECT; BLOOD VESSEL TONE; BREAST CANCER; CANCER CELL CULTURE; CARDIOVASCULAR SYMPTOM; CLINICAL RESEARCH; CORONARY ARTERY BLOOD FLOW; DRUG STRUCTURE; ESTROGEN ACTIVITY; HUMAN; POSTMENOPAUSE; PREMENOPAUSE; RECEPTOR INTRINSIC ACTIVITY; STRUCTURE ANALYSIS;

ESTROGENS; FEMALE; HUMANS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 33745699901     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2006.04.021     Document Type: Article

References (38)

1. Lösel R.M., Falkenstein E., Feuring M., et al. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev 83 (2003) 965-1016
2. Szego C.M., and Davis J.S. Adenosine 3′,5′-monophosphate in rat uterus: acute elevation by estrogen. Proc Natl Acad Sci USA 58 (1967) 1711-1718
3. Pietras R.J., and Szego C.M. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265 (1977) 69-72
4. Ho K.J., and Liao J.K. Nonnuclear actions of estrogen. Arterioscler Thromb Vasc Biol 22 (2002) 1952-1961
5. Orshal J.M., and Khalil R.A. Gender, sex hormones, and vascular tone. Am J Physiol: Regul Integr Comp Physiol 286 (2004) R233-R249
6. Reis S.E., Gloth S.T., Blumenthal R.S., et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 89 (1994) 52-60
7. Walker H.A., Dean T.S., Sanders T.A., Jackson G., Ritter J.M., and Chowienczyk P.J. The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17beta-estradiol. Circulation 103 (2001) 258-262
8. Chen Z., Yuhanna I.S., Galcheva-Gargova Z., Karas R.H., Mendelsohn M.E., and Shaul P.W. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103 (1999) 401-406
9. Haynes M.P., Sinha D., Russell K.S., et al. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 87 (2000) 677-682
10. Mendelsohn M.E., and Nongenomic. ER-mediated activation of endothelial nitric oxide synthase: how does it work? What does it mean?. Circ Res 87 (2000) 956-960
11. Bulayeva N.N., Gametchu B., and Watson C.S. Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Steroids 69 (2004) 181-192
12. Marin R., Guerra B., Morales A., Diaz M., and Alonso R. An ICI 182, 780-sensitive, membrane-related estrogen receptor contributes to estrogenic neuroprotective actions against amyloid-beta toxicity. Ann NY Acad Sci 1007 (2003) 108-116
13. Vasudevan N., Kow L.M., and Pfaff D.W. Early membrane estrogenic effects required for full expression of slower genomic actions in a nerve cell line. Proc Natl Acad Sci USA 98 (2001) 12267-12271
14. Razandi M., Pedram A., and Levin E.R. Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol Endocrinol 14 (2000) 1434-1447
15. Fernando R.I., and Wimalasena J. Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signaling through ERK and Akt. Mol Biol Cell 15 (2004) 3266-3284
16. Filardo E.J., Quinn J.A., Bland K.I., and Frackelton Jr. A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14 (2000) 1649-1660
17. Pietras R.J., Marquez D.C., Chen H.W., Tsai E., Weinberg O., and Fishbein M. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids 70 (2005) 372-381
18. Simoncini T., Genazzani A.R., and Liao J.K. Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation 105 (2002) 1368-1373
19. Mori-Abe A., Tsutsumi S., Takahashi K., et al. Estrogen and raloxifene induce apoptosis by activating p38 mitogen-activated protein kinase cascade in synthetic vascular smooth muscle cells. J Endocrinol 178 (2003) 417-426
20. Simoncini T., Varone G., Fornari L., et al. Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourth-generation selective estrogen receptor modulator. Endocrinology 143 (2002) 2052-2061
21. Kousteni S., Bellido T., Plotkin L.I., et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104 (2001) 719-730
22. Kousteni S., Chen J.R., Bellido T., et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298 (2002) 843-846
23. Chambliss K.L., Yuhanna I.S., Mineo C., et al. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 87 (2000) E44-E52
24. Abraham I.M., Todman M.G., Korach K.S., and Herbison A.E. Critical in vivo roles for classical estrogen receptors in rapid estrogen actions on intracellular signaling in mouse brain. Endocrinology 145 (2004) 3055-3061
25. Wong C.W., McNally C., Nickbarg E., Komm B.S., and Cheskis B.J. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 99 (2002) 14783-14788
26. Barletta F., Wong C.W., McNally C., Komm B.S., Katzenellenbogen B., and Cheskis B.J. Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc. Mol Endocrinol 18 (2004) 1096-1108
27. Gu Q., Korach K.S., and Moss R.L. Rapid action of 17beta-estradiol on kainate-induced currents in hippocampal neurons lacking intracellular estrogen receptors. Endocrinology 140 (1999) 660-666
28. Toran-Allerand C.D., Guan X., MacLusky N.J., et al. ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci 22 (2002) 8391-8401
29. Filardo E.J., Quinn J.A., Frackelton Jr. A.R., and Bland K.I. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16 (2002) 70-84
30. Thomas P., Pang Y., Filardo E.J., and Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146 (2005) 624-632
31. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., and Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307 (2005) 1625-1630
32. Pietras R.J., Levin E.R., and Szego C.M. Estrogen receptors and cell signaling. Science 310 (2005) 51-53
33. Nadal A., Ropero A.B., Laribi O., Maillet M., Fuentes E., and Soria B. Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha and estrogen receptor beta. Proc Natl Acad Sci USA 97 (2000) 11603-11608
34. Li J., and Chory J. A putative leucine-rich repeat receptor kinase involved in brassinosteroid signal transduction. Cell 90 (1997) 929-938
35. Norman A.W., Bishop J.E., Collins E.D., et al. Differing shapes of 1 alpha,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: a status report. J Steroid Biochem Mol Biol 56 (1996) 13-22
36. 2vitamin D3. Steroids 64 (1999) 120-128
37. Norman A.W., Mizwicki M.T., and Norman D.P. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 3 (2004) 27-41
38. Manson J.E., Hsia J., Johnson K.C., et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349 (2003) 523-534